Lexicon Pharmaceuticals, Inc.
LXRX

$258.36 M
Marketcap
$0.71
Share price
Country
$-0.01
Change (1 day)
$3.73
Year High
$0.62
Year Low
Categories

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The company has strategic collaboration and license agreements with Bristol-Myers Squibb Company, and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was incorporated in 1995 and is headquartered in The Woodlands, Texas.

marketcap

Stock price history for Lexicon Pharmaceuticals, Inc. (LXRX)

Highest end of day price: $329.88 USD on 2000-07-21

Lowest end of day price: $0.65 USD on 2024-12-05

Stock price history of Lexicon Pharmaceuticals, Inc. from 2000 to 2024